info@strategicmarketresearch.com
92, An Guha Lane, Arya Samaj Gali, Sambalpur, Odisha -768001
Indian Flag  IN: +91-826-083-6500
Home » therapeutics

therapeutics

Autoimmune Gastrointestinal Dysmotility Market By Treatment Type (Immunotherapy, Motility Agents, Symptom Management, Nutritional Support, Emerging Biologics); By Diagnostic Approach (Antibody Testing, GI Motility Testing, Imaging, Autonomic Testing, Molecular Diagnostics); By End User (Tertiary Care Hospitals, Specialty Clinics, Diagnostic Labs, Academic & Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Autoimmune Gastrointestinal Dysmotility Market is projected to grow at a CAGR of 8.9%, with an estimated value of USD 512.6 million in 2024 and forecasted to reach Read More

Published Date: JAN-2026 | No Of Pages:159 | $ 4485

Hydatidiform Mole Market By Diagnostic Method (Ultrasound Imaging, Blood Tests, Genetic Testing); By Treatment Option (Surgical Evacuation, Chemotherapy, Observation and Monitoring); By End User (Hospitals, Fertility Clinics, Diagnostic Imaging Centers, Research Institutes); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hydatidiform Mole Market is poised to experience steady growth, with a robust CAGR of 5.6% expected between 2024 and 2030. Valued at approximately Read More

Published Date: JAN-2026 | No Of Pages:167 | $ 4485

Anthrax Treatment Market By Product Type (Antibiotics, Vaccines, Monoclonal Antibodies, Other Therapies); By Treatment Application (Human Treatment, Veterinary Treatment); By End User (Hospitals, Veterinary Clinics, Government and Military, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Anthrax Treatment Market valued at USD 1.2 billion in 2024 and projected to reach USD 2.1 billion by 2030 at 7.5% CAGR, driven by biodefense progr... Read More

Published Date: JAN-2026 | No Of Pages:170 | $ 4485

Leber Congenital Amaurosis Market By Therapy Type (Gene Therapy, Pharmacological Therapy, Retinal Prosthetics); By Genetic Subtype (RPE65 Mutations, CEP290 Mutations, Other Rare Mutations); By End User (Specialty Ophthalmology Clinics, Hospitals and Eye Centers, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Leber Congenital Amaurosis Market valued at USD 1.2 billion in 2024 and projected to reach USD 1.7 billion by 2030 at 6.5% CAGR, driven by gene th... Read More

Published Date: JAN-2026 | No Of Pages:151 | $ 4485

Ovarian Cyst Management Market By Product Type (Diagnostic Products [Ultrasound, MRI, CT, Laparoscopic Cameras], Therapeutic Products [Hormonal Treatments, Surgical Devices, Pain Management Drugs]); By Treatment Method (Non-Invasive, Invasive); By End User (Hospitals, Gynecology Clinics, Diagnostic Imaging Centers, Fertility Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Ovarian Cyst Management Market projected to reach USD 4.8 billion by 2030 from USD 3.2 billion in 2024, registering 5.4% CAGR, supported by women ... Read More

Published Date: JAN-2026 | No Of Pages:180 | $ 4485

Anaplasmosis Treatment Market By Treatment Type (Antibiotics, Supportive Therapies, Experimental / Pipeline Therapies); By Route of Administration (Oral, Intravenous); By End User (Hospitals, Clinics and Outpatient Centers, Veterinary Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Anaplasmosis Treatment Market will witness a robust CAGR of 6.5%, valued at USD 420 million in 2024, expected to appreci... Read More

Published Date: JAN-2026 | No Of Pages:193 | $ 4485

Germ Cell Tumor Market By Tumor Type (Testicular Germ Cell Tumors, Ovarian Germ Cell Tumors, Extragonadal Germ Cell Tumors); By Treatment Modality (Chemotherapy, Surgery, Stem Cell Transplantation, Targeted & Immunotherapy); By End User (Specialized Cancer Centers, General Hospitals, Fertility Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Germ Cell Tumor GCT Market growing at 6.5% CAGR, expanding from USD 2.8 billion in 2024 to USD 4.1 billion by 2030, driven by market growth, indus... Read More

Published Date: JAN-2026 | No Of Pages:173 | $ 4485

Palmoplantar Pustulosis (PPP) Market By Treatment Type (Topical Therapies, Systemic Non-Biologics, Biologics, Phototherapy); By Route of Administration (Topical, Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa); Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Palmoplantar Pustulosis Market is projected to expand steadily between 2024 and 2030, with an estimated value of USD 780 million in 2024 ... Read More

Published Date: JAN-2026 | No Of Pages:196 | $ 4485

Geographic Atrophy Market By Therapy Type (Complement Inhibitors, Gene Therapy & Regenerative Approaches, Small Molecules & Others); By Route of Administration (Intravitreal Injections, Oral & Topical Routes, Sustained-Release Implants); By End User (Specialty Ophthalmology Clinics, Hospitals & Academic Centers, Ambulatory Surgical Centers, Community Eye Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Geographic Atrophy Market growing at 8.5% CAGR, expanding from USD 2.3 billion in 2024 to USD 4.0 billion by 2030, driven by market growth, indust... Read More

Published Date: JAN-2026 | No Of Pages:175 | $ 4485

Gynecomastia Treatment Market By Treatment Type (Surgical, Non-Surgical); By End User (Hospitals, Aesthetic Clinics, Ambulatory Surgical Centers, Endocrinology Clinics); By Age Group (Adolescents, Adults, Middle-Aged & Older); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Gynecomastia Treatment Market valued at USD 1.72 billion in 2024 and projected to reach USD 2.56 billion by 2030 at 6.8% CAGR, supported by indust... Read More

Published Date: JAN-2026 | No Of Pages:195 | $ 4485

JAK3 Inhibitor Market By Product Type (Selective JAK3 Inhibitors, Pan-JAK Inhibitors with JAK3 Activity); By Therapeutic Indication (Rheumatoid Arthritis, Psoriasis, Ulcerative Colitis, Hematologic Malignancies, Others); By Route of Administration (Oral, Parenteral); By End User (Hospitals, Specialty Clinics, Retail Pharmacies & Outpatient Centers, Academic & Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global JAK3 Inhibitor Market will witness a robust CAGR of 9.1%, valued at USD 2.3 billion in 2024, and expected to reach Read More

Published Date: JAN-2026 | No Of Pages:168 | $ 4485

Carboxy Therapy Market By Product Type (Professional Devices, At-Home Kits); By Application (Aesthetic, Medical/Therapeutic); By End User (Aesthetic Clinics & Dermatology Centers, Hospitals & Medical Centers, Wellness & Spa Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Carboxy Therapy Market growing at 12.3% CAGR, expanding from USD 1.2 billion in 2024 to USD 2.3 billion by 2030, driven by market growth, industry... Read More

Published Date: JAN-2026 | No Of Pages:197 | $ 4485

Pulmonary Drug Delivery Systems Market By Product Type (MDIs, DPIs, Nebulizers, Smart Inhalers); By Application (Asthma, COPD, Cystic Fibrosis, Pulmonary Arterial Hypertension, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pulmonary Drug Delivery Systems Market growing at 7.2% CAGR, expanding from USD 58.7 billion in 2024 to USD 89.4 billion by 2030, fueled by market... Read More

Published Date: JAN-2026 | No Of Pages:162 | $ 4485

Endothelial Dysfunction Market By Product Type (Diagnostics, Therapeutics, Digital Health Solutions); By Application (Cardiovascular Risk, Metabolic Syndrome, Chronic Kidney Disease, Others); By End User (Hospitals, Diagnostic Laboratories, Specialty Clinics, Primary Care Providers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Endothelial Dysfunction Market growing at 7.4% CAGR, expanding from $2.8 billion in 2024 to $4.7 billion by 2030, driven by market growth, industr... Read More

Published Date: JAN-2026 | No Of Pages:169 | $ 4485

Low-Grade Glioma Market By Treatment Type (Surgery, Chemotherapy, Targeted Therapy, Radiotherapy, Surveillance); By Tumor Subtype (Astrocytoma, Oligodendroglioma, Mixed Glioma); By End User (Academic Centers, Community Hospitals, Diagnostic Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Low-Grade Glioma Market growing at 5.8% CAGR, expanding from $1.4 billion in 2024 to $2.0 billion by 2030, driven by market growth, industry analy... Read More

Published Date: JAN-2026 | No Of Pages:178 | $ 4485

Gastroesophageal Junction Adenocarcinoma Market By Therapy Type (Targeted Therapy, Immunotherapy, Chemotherapy, Surgical Intervention); By Diagnostic Approach (Imaging, Histopathology, Molecular Diagnostics); By End User (Hospitals, Oncology Clinics, Reference Laboratories); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Gastroesophageal Junction Adenocarcinoma Market is set to experience notable growth between 2024 and 2030, the market is valued at an estimated $2.2 billion in 2024 and is projected to rea... Read More

Published Date: JAN-2026 | No Of Pages:191 | $ 4485

Whim Syndrome Management Market By Drug Type (G-CSFs, Immunoglobulin Therapy, CXCR4 Antagonists); By Route of Administration (Subcutaneous, Intravenous, Oral); By End User (Hospitals, Specialty Clinics, Pediatric Tertiary Centers, Home Care); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Whim Syndrome Management Market is expected to advance at a steady CAGR of 10.1%, valued at around $54 million in 2024 and projected to reach nearly $96 million by... Read More

Published Date: JAN-2026 | No Of Pages:184 | $ 4485

Pollen Allergy Market By Treatment Type (Pharmacotherapy, Immunotherapy [SCIT, SLIT], Biologic Therapies); By Route of Administration (Oral, Nasal, Injectable); By Distribution Channel (Hospital & Allergy Clinics, Retail Pharmacies, Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pollen Allergy Market is projected to grow at a steady CAGR of 5.8%, valued at USD 8.9 billion in 2024, and anticipated to reach USD 12.5 billion by 2030,... Read More

Published Date: JAN-2026 | No Of Pages:168 | $ 4485

Pemphigus Vulgaris Market By Treatment Type (Corticosteroids, Immunosuppressants, Monoclonal Antibodies, Small Molecules); By Route of Administration (Oral, Intravenous, Subcutaneous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pemphigus Vulgaris Market is forecast to grow at a CAGR of 6.5%, increasing from USD 708 million in 2024 to USD 1.04 billion by 2030, driven by bi... Read More

Published Date: JAN-2026 | No Of Pages:198 | $ 4485

Undescended Testicle Market By Treatment Type (Surgery, Hormonal Therapy); By Age Group (Infants, Toddlers, Older Children); By End User (Pediatric Hospitals, General Hospitals, Specialty Clinics, Outpatient Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Undescended Testicle Market is expected to post a steady CAGR of 6.8% , with an estimated market value of USD 460 million in 2024 and a p... Read More

Published Date: JAN-2026 | No Of Pages:195 | $ 4485

Spina Bifida In-Utero Market By Procedure Type (Open Fetal Surgery, Minimally Invasive/Fetoscopic Repair); By Application (Myelomeningocele Correction, Other Neural Tube Defects); By End User (Academic Hospitals, Children’s Hospitals, Regional Perinatal Centers, General Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Spina Bifida In-Utero Market will expand at a consistent CAGR of 8.6%, moving from USD 397 million in 2024 to USD 650 million by 2030, propelled by Read More

Published Date: JAN-2026 | No Of Pages:152 | $ 4485

Sialorrhea Treatment Market By Product Type (Anticholinergic Drugs, Botulinum Toxin, Devices, Others); By Route of Administration (Oral, Injectable, Surgical, Others); By End User (Hospitals, Specialty Clinics, Long-Term Care Facilities, Homecare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Sialorrhea Treatment Market is poised for steady growth, with an estimated CAGR of 6.1% , valued at about USD 1.21 billion in 2024 and anticipated to reach USD 1.7... Read More

Published Date: JAN-2026 | No Of Pages:192 | $ 4485

Ophthalmoplegia Market By Type (External Ophthalmoplegia, Internal Ophthalmoplegia, Complete Ophthalmoplegia); By Cause (Stroke, Diabetes, Autoimmune Disorders, Mitochondrial Disease, Tumors); By Treatment (Pharmacological, Surgical, Botulinum Toxin, Rehabilitation); By End User (Tertiary Hospitals, Specialty Clinics, Rehabilitation Centers, Surgical Eye Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Ophthalmoplegia Market is expected to grow at a steady CAGR of 5.8%, valued at USD 1.2 billion in 2024, and projected to surpass USD 1.7 billion by 2030, ... Read More

Published Date: JAN-2026 | No Of Pages:151 | $ 4485

Muckle Wells Syndrome Market By Therapy Type (IL-1 Inhibitors, Corticosteroids & NSAIDs, Emerging Agents); By Route of Administration (Injectable, Oral); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Muckle Wells Syndrome Market is anticipated to see steady but specialized growth over the forecast period, with an CAGR of 6.5% . The mar... Read More

Published Date: JAN-2026 | No Of Pages:159 | $ 4485

Hyperhidrosis Treatment Market By Treatment Type (Botox Injections, Iontophoresis, Microwave Therapy, Surgical Procedures, Topical Treatments); By End User (Dermatology Clinics, Hospitals, Outpatient Clinics, Home Care); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hyperhidrosis Treatment Market is expected to expand at a CAGR of 7.5% from 2024 to 2030, increasing from $4.1 billion in 2024 to $6.8 Billion in 2030, fu... Read More

Published Date: JAN-2026 | No Of Pages:181 | $ 4485

Human Osteoblasts Market by Type (Primary Osteoblasts, Induced Osteoblasts, Stem Cell-Derived Osteoblasts); By Application (Bone Regeneration, Osteoporosis Treatment, Fracture Healing, Bone Cancer Research); By End-User (Hospitals, Research Institutes, Biotech Companies, Imaging Centers, ASCs); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Human Osteoblasts Market is projected to grow from an estimated USD 3.5 billion in 2024 to USD 6.5 billion by 2030, with a CAGR of 10% during this period, driven... Read More

Published Date: JAN-2026 | No Of Pages:176 | $ 4485

Homozygous Familial Hypercholesterolemia Market By Drug Class (Statins, PCSK9 Inhibitors, Lomitapide, Gene Therapy, RNA-based Therapeutics); By Route of Administration (Oral, Subcutaneous, Intravenous); By Patient Age Group (Pediatric, Adult); By End User (Specialty Lipid Clinics, Academic Hospitals, General Hospitals, Payers/Managed Care); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Homozygous Familial Hypercholesterolemia Market is set to witness CAGR of 11.3%, growing from $1.14 billion in 2024 to $2.15 billion by 2030, driven by Read More

Published Date: JAN-2026 | No Of Pages:169 | $ 4485

Histoplasmosis Treatment Market By Drug Type (Azoles, Polyenes, Adjunctive Therapies); By Route of Administration (Oral, Intravenous); By Patient Group (Immunocompromised, Immunocompetent); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Histoplasmosis Treatment Market will grow at a CAGR of 6.3%, with a valuation of USD 1.6 billion in 2024 and expected to hit USD 2.3 billion by 2030, supp... Read More

Published Date: JAN-2026 | No Of Pages:194 | $ 4485

Group B Streptococcus Infection Treatment Market By Drug Class (Beta-lactam Antibiotics, Clindamycin & Alternatives, Pipeline Therapies); By Route of Administration (Intravenous, Oral); By End User (Hospitals, Maternity Clinics & Birthing Centers, Diagnostic Laboratories); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Group B Streptococcus (GBS) Infection Treatment Market is set to witness a steady CAGR of 5.4% , valued... Read More

Published Date: JAN-2026 | No Of Pages:186 | $ 4485

Gingival Recession Market By Product Type (Soft Tissue Grafts, Regenerative Biomaterials, Dental Membranes, Growth Factors); By Treatment Approach (Surgical Flap Procedures, Connective Tissue Grafts, Guided Tissue Regeneration); By End User (Private Clinics, Hospitals, Academic Institutions, Specialty Periodontal Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Gingival Recession Market is expected to grow steadily, with an valuation of 1.9 billion USD in 2024 and projected to reach 2.8 billion USD by 2030 . This reflects a Read More

Published Date: JAN-2026 | No Of Pages:152 | $ 4485

Familial Adenomatous Polyposis Treatment Market By Treatment Type (Pharmacologic Therapy, Surgical Intervention, Gene Therapy); By End User (Hospitals, Specialty Clinics, Research Centers); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Familial Adenomatous Polyposis Treatment Market is poised to grow at a robust CAGR of 8.2%, valued at USD 1.3 billion in 2024 and projected to reach USD 2.1 billio... Read More

Published Date: JAN-2026 | No Of Pages:150 | $ 4485

Recurrent Pericarditis Market by Treatment Type (Biologic Therapies, NSAIDs, Colchicine, Corticosteroids, Surgical Interventions); By End User (Hospitals, Specialty Clinics, Diagnostic Imaging Centers, Ambulatory Surgical Centers); By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa); Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Recurrent Pericarditis Market will expand steadily at a CAGR of 6.5%, reaching $2.1 billion by 2030 from $1.2 billion in 2024, supported by cardia... Read More

Published Date: JAN-2026 | No Of Pages:192 | $ 4485

Postoperative Pain Management Market By Product Type (Non-Opioid Analgesics, Opioid Analgesics, Local Anesthetics, Adjuvant Therapies, Devices, Digital Solutions); By Route of Administration (Oral, Intravenous, Regional, Transdermal, Others); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Home Healthcare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Postoperative Pain Management Market is set to expand at a CAGR of 6.1%, with a market value of USD 13.2 billion in 2024, projected to reach USD 18.8 billion by 20... Read More

Published Date: JAN-2026 | No Of Pages:173 | $ 4485

Bladder Cancer Therapeutics Market By Therapy Type (Chemotherapy, Immunotherapy, Targeted Therapy, Intravesical Therapy, Combination Therapy); By Disease Stage (Non-Muscle-Invasive Bladder Cancer, Muscle-Invasive Bladder Cancer, Metastatic Bladder Cancer); By Route of Administration (Intravenous, Oral, Intravesical); By End User (Hospitals and Cancer Centers, Specialty Urology Clinics, Ambulatory Surgical Centers, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Bladder Cancer Therapeutics Market will witness steady expansion at a CAGR of 7.6%, valued at USD 4.2 billion in 2024 and projected to reach USD 6.52 billion by 20... Read More

Published Date: JAN-2026 | No Of Pages:151 | $ 4485

Giant Cell Arteritis Market By Therapy Type (Corticosteroids, Biologics, Supportive Therapies); By Route of Administration (Oral, Injectable [Subcutaneous, Intravenous]); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Giant Cell Arteritis (GCA) Market will witness steady expansion, valued at USD 1.3 billion in 2024 and projected to reach USD 2.1 billion by 2030, growing at a CAG... Read More

Published Date: JAN-2026 | No Of Pages:166 | $ 4485

Giant Papillary Conjunctivitis Market By Treatment Type (Antihistamines & Mast Cell Stabilizers, Corticosteroids, Immunomodulators, Lubricants & Supportive Care); By Route of Administration (Topical Eye Drops, Ophthalmic Inserts, Systemic Therapy); By Distribution Channel (Retail Pharmacies & Drug Stores, Online Pharmacies, Hospital & Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2025–2030.

Introduction And Strategic Context

The Global Giant Papillary Conjunctivitis (GPC) Market is projected to grow at a CAGR of 6.5% between 2024 and 2030, climbing from an estimated value of USD 1.26 billion in 2024 to a... Read More

Published Date: JAN-2026 | No Of Pages:197 | $ 4485

Giant Axonal Neuropathy Market By Treatment Type (Gene Therapy, Antisense Oligonucleotides, Supportive & Symptomatic Care); By Route of Administration (Intrathecal, Intravenous, Oral & Others); By End User (Academic & Research Hospitals, Specialty Neurology Clinics, Pediatric Rehabilitation Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Giant Axonal Neuropathy (GAN) Market is projected to grow at a CAGR of 19.8% between 2024 and 2030, with an estimated market size of USD 78.2 million in 2024 and reaching ... Read More

Published Date: JAN-2026 | No Of Pages:187 | $ 4485

Gestational Diabetes Market By Treatment Type (Insulin Therapy, Oral Hypoglycemic Agents, Lifestyle & Nutritional Management); By Diagnostic Approach (OGTT & GCT, HbA1c Testing, Continuous Glucose Monitoring); By End User (Hospitals & Maternity Clinics, Diagnostic Laboratories, Digital Health Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Gestational Diabetes Market is projected to grow at a steady CAGR of 6.7%, valued at USD 2.8 billion in 2024 and anticipated to reach USD 4.1 billion by 2030Read More

Published Date: JAN-2026 | No Of Pages:159 | $ 4485

Frontotemporal Dementia Market By Product Type (Therapeutics, Diagnostics); By Therapeutic Approach (Tau-Targeted Therapies, TDP-43 Modulators, Symptomatic Management); By End User (Hospitals & Memory Clinics, Specialty Neurology Centers, Research Institutes, Home & Outpatient Care); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Frontotemporal Dementia Market valued at USD 1.9 billion in 2024 and expected to reach USD 2.9 billion by 2030 at 6.8%, CAGR, driven by clinical t... Read More

Published Date: JAN-2026 | No Of Pages:192 | $ 4485

Excessive Daytime Sleepiness Market By Drug Class (Stimulants, Wakefulness-Promoting Agents, Non-Stimulant Therapies, Digital Therapeutics); By Underlying Condition (Obstructive Sleep Apnea, Narcolepsy, Idiopathic Hypersomnia, Shift Work Sleep Disorder); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online/Telehealth Channels); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Excessive Daytime Sleepiness Market is anticipated to expand at a CAGR of 8.1%, estimated at $4.3 billion in 2024 and projected to reach $6.8 billion by 2030Read More

Published Date: JAN-2026 | No Of Pages:199 | $ 4485

Erosive Hand Osteoarthritis Market By Treatment Type (Pharmacological Treatment, Surgical Treatment, Non-Pharmacological Treatment); By End User (Hospitals, Specialty Clinics, Outpatient Care Centers); By Region, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Erosive Hand Osteoarthritis Market is poised to grow at a CAGR of 6.3% , reaching an estimated value of USD 1.12 billion by 2030 , up from USD 780... Read More

Published Date: JAN-2026 | No Of Pages:158 | $ 4485

Epithelioid Sarcoma Treatment Market By Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy, Surgery, Radiation Therapy); By Route of Administration (Oral, Intravenous, Subcutaneous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Epithelioid Sarcoma Treatment Market is projected to reach USD 1.36 billion by 2030 , up from an estimated USD 820 million in 2024 , expanding at a Read More

Published Date: JAN-2026 | No Of Pages:150 | $ 4485

Emphysema Market By Treatment Type (Inhaled Medications, Biologics, Surgical & Device-Based Interventions, Pulmonary Rehabilitation & Oxygen Therapy); By Route of Administration (Inhalation, Oral, Injectable/Biologic); By End User (Hospitals, Retail Pharmacies, Homecare Providers, Payers); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Emphysema Market is projected to grow steadily between 2024 and 2030, valued at USD 6.8 billion in 2024 and forecasted to reach USD 9.7 billion by 2030 , ... Read More

Published Date: JAN-2026 | No Of Pages:166 | $ 4485

Ebola Fever Therapeutics Market By Product Type (Monoclonal Antibody Therapies, Antiviral Agents, RNA-Based Therapeutics, Supportive Therapies & Immunomodulators); By Route of Administration (Intravenous, Oral, Intramuscular/Subcutaneous); By Distribution Channel (Government & Public Health Procurement, NGOs & Humanitarian Agencies, Hospital Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2025–2030.

Introduction And Strategic Context

The Global Ebola Fever Therapeutics Market is projected to expand steadily at a CAGR of 6.9% , growing from an estimated USD 1.02 billion in... Read More

Published Date: JAN-2026 | No Of Pages:165 | $ 4485

Diverticulitis Market By Treatment Type (Medical, Surgical); By Product Type (Pharmaceuticals, Nutritional Therapies, Surgical Devices, Digital Monitoring Tools); By Disease Type (Uncomplicated, Complicated); By End User (Hospitals, Gastroenterology Clinics, Ambulatory Surgical Centers, Imaging Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Diverticulitis Market expanding from USD 4.1 billion in 2024 to USD 6.0 billion by 2030 at a CAGR of 6.5%, reflecting market growth, Read More

Published Date: JAN-2026 | No Of Pages:158 | $ 4485

Diarrhea Therapeutics Market By Drug Class (Oral Rehydration Salts, Anti-Motility Agents, Antibiotics, Probiotics, Zinc Supplements); By Route of Administration (Oral, Intravenous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Diarrhea Therapeutics Market will witness a steady CAGR of 5.8% , valued at USD 9.6 billion in 2024 and expected to reac... Read More

Published Date: JAN-2026 | No Of Pages:199 | $ 4485

Congenital Adrenal Hyperplasia Treatment Market By Drug Type (Glucocorticoids, Mineralocorticoids, Steroidogenesis Inhibitors, CRF1 Receptor Antagonists); By Route of Administration (Oral, Injectable, Transdermal); By Age Group (Pediatric, Adolescent, Adult); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Congenital Adrenal Hyperplasia (CAH) Treatment Market will register growth at a CAGR of 6.8%, expanding from USD 472 million in 2024 to USD 703 million by 2030Read More

Published Date: JAN-2026 | No Of Pages:185 | $ 4485

Clinically Isolated Syndrome Market By Drug Class (Injectables, Oral Therapies, Monoclonal Antibodies); By Diagnostic Tool (MRI, CSF Analysis, Optical Coherence Tomography, Evoked Potentials); By Patient Type (Adults, Pediatric Onset, High-Risk Patients); By End User (Neurology Clinics, Imaging Centers, Hospitals, Academic Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Clinically Isolated Syndrome (CIS) Market is projected to grow at a steady CAGR of 6.5% , reaching an estimated value of $2.6 billion by 2030Read More

Published Date: JAN-2026 | No Of Pages:155 | $ 4485

Clear Cell Ovarian Cancer Market By Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy, Surgical Intervention); By Disease Stage (Stage I–II, Stage III–IV); By End User (Academic & Research Hospitals, Cancer Specialty Centers, General Hospitals, Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Clear Cell Ovarian Cancer Market is projected to expand at a CAGR of 6.8%, reaching approximately USD 1.9 billion by 2030, up from an estimated USD 1.3 billion in ... Read More

Published Date: JAN-2026 | No Of Pages:164 | $ 4485

Chronic Traumatic Encephalopathy Market By Diagnostic Type (Neuroimaging, Blood Biomarkers, Neurocognitive Tools); By Intervention Type (Symptom Management Drugs, Neuroprotective Therapies, Behavioral & Cognitive Therapy); By End User (Neurology Clinics, Sports Medicine Institutions, Veteran Health Systems, Academic Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Chronic Traumatic Encephalopathy (CTE) Market is forecast to grow from USD 1.2 billion in 2024 to USD 2.1 billion by 2030, registering a CAGR of 9.1%, sup... Read More

Published Date: JAN-2026 | No Of Pages:192 | $ 4485

Chronic Myelomonocytic Leukemia Market By Treatment Type (Hypomethylating Agents, Targeted Therapies, Stem Cell Transplantation, Supportive Care); By Route of Administration (Injectable, Oral); By End User (Academic Medical Centers, Community Oncology Clinics, Transplant Centers, Specialized Hematology Units); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Chronic Myelomonocytic Leukemia (CMML) Market was valued at approximately USD 720 Million in 2024 and is projected to surpass USD 1.1 Billion by 2030, expanding at aRead More

Published Date: JAN-2026 | No Of Pages:180 | $ 4485

Chronic Idiopathic Urticaria Treatment Market By Drug Class (Antihistamines, Monoclonal Antibodies, Leukotriene Receptor Antagonists, Immunosuppressants); By Route of Administration (Oral, Subcutaneous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Chronic Idiopathic Urticaria Treatment Market is anticipated to grow from USD 4.8 billion in 2024 to around USD 7.6 billion by 2030, achieving a CAGR of 7.9% (2024... Read More

Published Date: JAN-2026 | No Of Pages:187 | $ 4485

Cervical Intraepithelial Neoplasia Market By CIN Grade (CIN I, CIN II, CIN III); By Diagnostic Method (Pap Smear, HPV Testing, Colposcopy, Biomarker Triage); By Treatment (Cryotherapy, LEEP, Cold Knife Conization, Immunotherapy); By End User (Hospitals, Specialty Clinics, Diagnostic Labs, Community Health Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Cervical Intraepithelial Neoplasia (CIN) Market will witness a steady CAGR of 6.8%, valued at USD 1.32 billion in 2024, and projected to ... Read More

Published Date: JAN-2026 | No Of Pages:185 | $ 4485

Cerebrotendinous Xanthomatosis Market By Treatment Type (Chenodeoxycholic Acid, Adjunctive Therapies, Pipeline/Investigational Drugs); By Route of Administration (Oral, Future-IV/Subcutaneous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online/Compounding Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cerebrotendinous Xanthomatosis Market is projected to grow at a CAGR of 6.7% , with a market value of USD 223.0<... Read More

Published Date: JAN-2026 | No Of Pages:188 | $ 4485

Cardiovascular Calcification Market By Product Type (Imaging Systems, Atherectomy Devices, Drug-Eluting Stents, Transcatheter Heart Valves); By Application (Coronary Artery Disease, Aortic Valve Stenosis, Peripheral Artery Disease, CKD-Related Vascular Calcification); By End User (Hospitals, Ambulatory Surgical Centers, Cardiac Clinics, Dialysis & Nephrology Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cardiovascular Calcification Market is projected to rise at a CAGR of 6.5%, valued at USD 2.9 billion in 2024 and expected to reach USD 4.3 billion by 2030Read More

Published Date: JAN-2026 | No Of Pages:190 | $ 4485

Cannabis Use Disorder Market By Treatment Type (Pharmacological, Non-Pharmacological); By Delivery Channel (Outpatient Clinics, Digital Therapeutics, Primary Care, University Programs); By Patient Demographics (Age Group, Gender); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Cannabis Use Disorder Market is projected to reach $3.1 billion in 2030 , up from an estimated $1.8 billion in 2024 , growing at a CAGR of 9.4% during the... Read More

Published Date: JAN-2026 | No Of Pages:189 | $ 4485

Bronchiolitis Obliterans Syndrome Market By Treatment Type (Immunosuppressants, Corticosteroids, Macrolides, Antifibrotics); By Application (Lung Transplant-Associated BOS, HSCT-Associated BOS); By Route of Administration (Oral, Inhalation, Intravenous); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Bronchiolitis Obliterans Syndrome Market will grow at a CAGR of 6.5% , valued at nearly USD 1.42 billion in 2024 and projected to reach around USD 2.08 billion by ... Read More

Published Date: JAN-2026 | No Of Pages:178 | $ 4485

Bronchial Spasm Market By Drug Type (Short-acting β2-Agonists, Long-acting Bronchodilators, Anticholinergics, Leukotriene Receptor Antagonists); By Route of Administration (Inhaled [MDI, DPI], Nebulized, Oral, Others); By End User (Hospitals, Specialty Clinics, Homecare Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Bronchial Spasm Market is projected to grow at a steady CAGR of 6.4% , increasing from a market value of USD 1.42 billion in 2024 to USD 2.07 billion by 2030Read More

Published Date: JAN-2026 | No Of Pages:163 | $ 4485

Blastomycosis Treatment Market By Treatment Type (Antifungal Drugs, Surgical Intervention); By End-User (Hospitals, Outpatient Clinics, Diagnostic Laboratories); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Blastomycosis Treatment Market is valued at USD 3.4 billion in 2024 and is expected to reach USD 5.7 billion by 2030, growing at a Read More

Published Date: JAN-2026 | No Of Pages:195 | $ 4485

BK Virus Infection Market By Product Type (Diagnostic Tests, Therapeutic Solutions); By Application (Organ Transplants, Immunocompromised Patients); By End-User (Hospitals & Transplant Centers, Diagnostic Laboratories, Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global BK Virus Infection Market is valued at approximately USD 500 million in 2024, projected to reach USD 750 million by 2030, progressing at a CAGR of 7% from 2024 to ... Read More

Published Date: JAN-2026 | No Of Pages:176 | $ 4485

Bacterial Vaginosis Treatment Market By Treatment Type (Antibiotic Treatments, Probiotics-based Therapy, Topical Treatments, Oral Medications); By End-User (Hospitals & Clinics, Retail Pharmacies, Online Platforms, Diagnostic Imaging Centers, Gynecologists & General Practitioners); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Bacterial Vaginosis Treatment Market will witness steady growth, with a projected CAGR of 5.5% from 2024 to 2030. The market was valued at approximately USD 1.3 bi... Read More

Published Date: JAN-2026 | No Of Pages:176 | $ 4485

Asperger Syndrome Treatment Market By Treatment Type (Behavioral Therapy, Occupational & Speech Therapy, Pharmacological Treatment, Digital Therapeutics & Assistive Technologies); By Age Group (Children, Adolescents, Adults); By End User (Specialty Clinics, Hospitals & Diagnostic Centers, Educational Institutions, Home-Based & Remote Therapy Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Asperger Syndrome Treatment Market expanding with 8.9% CAGR and reaching approximately USD 3.7 billion by 2030 from USD 2.1 billion in 2024, led by Read More

Published Date: JAN-2026 | No Of Pages:157 | $ 4485

Arteriovenous Malformations Market By Treatment Type (Embolization, Stereotactic Radiosurgery, Microsurgical Resection, Pharmacological Management); By Diagnostic Modality (DSA, MRI/MRA, CT Angiography, Functional Imaging); By Anatomical Location (Cerebral AVMs, Spinal AVMs, Peripheral AVMs, Visceral AVMs); By End User (Tertiary Hospitals, Academic Centers, General Hospitals, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Arteriovenous Malformations (AVM) Market is projected to grow at a 6.4% CAGR, rising from USD 2.7 billion in 2024 to USD 4.1 billion by 2030, driven by neurovascular treat... Read More

Published Date: JAN-2026 | No Of Pages:170 | $ 4485

Aplastic Anemia Treatment Market By Treatment Type (Immunosuppressive Therapy, Bone Marrow Transplantation, Supportive Care, Others); By Drug Class (Anti-thymocyte Globulin [ATG], Cyclosporine, Eltrombopag, Others); By End User (Hospitals, Specialty Clinics, Research & Academic Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Aplastic Anemia Treatment Market is projected to grow at a robust 8.9% CAGR, rising from USD 1.32 billion in 2024 to nearly USD 2.19 billion by 2030, driv... Read More

Published Date: JAN-2026 | No Of Pages:180 | $ 4485

Stuttering Treatment Market By Treatment Type (Speech Therapy, Digital & App-Based Therapy, Pharmacological Treatment, Assistive Devices & Wearables); By Age Group (Children, Adolescents, Adults); By End User (Speech & Language Clinics, Hospitals & Rehabilitation Centers, Schools & Educational Institutions, Direct-to-Consumer Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Stuttering Treatment Market is forecast to grow at CAGR of 6.8%, increasing from USD 3.1 billion in 2024 to nearly USD 4.6 billion by 2030, fueled by Read More

Published Date: JAN-2026 | No Of Pages:157 | $ 4485

Radiodermatitis Market By Product Type (Topical Agents, Oral Medications, Dressings and Hydrogel Pads, Barrier Films and Sprays, Radioprotective Drugs); By Stage of Severity (Grade 1, Grade 2, Grade 3+); By End User (Hospitals, Specialty Dermatology Clinics, Ambulatory Radiation Centers, Retail Pharmacies & Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Radiodermatitis Market is poised for steady expansion at a CAGR of 6.3%, valued at USD 488.1 million in 2024 and projected to hit USD 746.2 million by 2030Read More

Published Date: JAN-2026 | No Of Pages:195 | $ 4485

Soft Tissue Sarcoma Treatment Market By Treatment Type (Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy, Immunotherapy); By Disease Subtype (Gastrointestinal Stromal Tumors, Liposarcoma, Leiomyosarcoma, Others); By End User (Hospitals & Specialty Cancer Centers, Academic & Research Institutes, Ambulatory & Outpatient Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Soft Tissue Sarcoma Treatment Market is valued at USD 4.7 billion in 2024, and it is projected to reach USD 7.9 billion by 2030, reflecti... Read More

Published Date: JAN-2026 | No Of Pages:153 | $ 4485

Polymyalgia Rheumatica Treatment Market By Drug Class (Corticosteroids, Immunosuppressants, Biologics); By Route of Administration (Oral, Parenteral); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Polymyalgia Rheumatica Treatment Market will witness a moderate CAGR of 5.6%, valued at USD 1.32 billion in 2024 and projected to reach USD 1.84 billion by 2030Read More

Published Date: JAN-2026 | No Of Pages:160 | $ 4485

Hereditary Transthyretin Amyloidosis Market By Treatment Type (TTR Stabilizers, Gene Silencing Therapies, Symptomatic Treatments); By Diagnostic Method (Genetic Testing, Imaging, Biomarker Testing); By End User (Hospitals, Specialty Clinics, Diagnostic Imaging Centers, Research Institutions); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hereditary Transthyretin Amyloidosis Market is valued at approximately USD 1.2 billion in 2024 and is expected to grow to USD 2.5 billion by 2030, representing a robust Read More

Published Date: JAN-2026 | No Of Pages:163 | $ 4485

Hypoparathyroidism Treatment Market By Drug Type (Calcium Supplements, Vitamin D Analogs, Recombinant PTH Therapies); By Route of Administration (Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hypoparathyroidism Treatment Market is projected to grow at a CAGR of 8.1%, valued at USD 1.14 billion in 2024 and expected to reach USD 1.82 billion by 2030Read More

Published Date: JAN-2026 | No Of Pages:176 | $ 4485

Herpes Labialis Treatment Market By Treatment Type (Oral Antivirals, Topical Antivirals, OTC Products, Vaccines); By End-User (Consumers, Healthcare Providers, Retail Pharmacies, Online Pharmacies); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Herpes Labialis Treatment Market was valued at USD 4.5 billion in 2024, and is projected to grow at a CAGR of 6.4%, reac... Read More

Published Date: JAN-2026 | No Of Pages:197 | $ 4485

Neurotrophic Keratitis Treatment Market By Treatment Type (Artificial Tears & Lubricants, Biologics [rhNGF, Serum Drops], Amniotic Membrane Products); By Disease Stage (Stage 1, Stage 2, Stage 3); By End User (Tertiary Eye Hospitals, Private Clinics, General Hospitals, Compounding Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Neurotrophic Keratitis Treatment Market is anticipated to progress at CAGR of 9.1%, increasing from USD 186.5 million in 2024 to USD 314.7 million by 2030... Read More

Published Date: JAN-2026 | No Of Pages:188 | $ 4485

Necrotising Enterocolitis Market By Product Type (Pharmaceutical Interventions, Nutritional Therapies, Diagnostic Tools, Surgical Equipment); By End User (Neonatal Intensive Care Units, Pediatric & Maternity Hospitals, Research Institutes); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Necrotising Enterocolitis ( NEC ) Market is projected to grow at a CAGR of 6.8%, increasing from an estimated USD 460 million in 2024 to ... Read More

Published Date: JAN-2026 | No Of Pages:157 | $ 4485

Palmoplantar Keratoderma Market By Type (Hereditary PPK, Acquired PPK); By Treatment (Topical Therapies, Systemic Therapies, Gene & Molecular Therapies); By End User (Specialty Dermatology Clinics, General Dermatology Practices, Retail & Online Pharmacies, Teledermatology Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Palmoplantar Keratoderma ( PPK ) Market is projected to grow steadily over the next several years, reaching a valuation of $1.04 billion by 2030, up from ... Read More

Published Date: JAN-2026 | No Of Pages:164 | $ 4485

Retinitis Pigmentosa Market By Treatment Type (Gene Therapy, Stem Cell Therapy, Optogenetics & Prosthetics, Adjunct Therapies); By Route of Administration (Intraocular, Oral/Systemic, Sustained-Release Ocular Implants); By End User (Specialized Ophthalmology Centers, Academic Hospitals, General Hospitals, Diagnostic Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Retinitis Pigmentosa Market growing at 5.8% CAGR, with USD 560 million in 2024 to USD 785 million by 2030, driven by retinitis pigmentosa treatmen... Read More

Published Date: JAN-2026 | No Of Pages:184 | $ 4485

Pyoderma Gangrenosum Treatment Market By Treatment Type (Topical Treatments, Systemic Treatments, Surgical Treatments); By End User (Hospitals, Dermatology Clinics, Outpatient Care Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pyoderma Gangrenosum Treatment Market will witness steady growth from USD 1.2 billion in 2024 to USD 2.3 billion by 2030 at a CAGR of 10.6%, supported by ... Read More

Published Date: JAN-2026 | No Of Pages:153 | $ 4485

Pediatric Brain Tumor Market By Imaging Modality (MRI, CT, Ultrasound, Functional MRI, Low-Dose CT); By Tumor Type (Gliomas, Medulloblastomas, Neuroblastomas, Others); By End-User (Children’s Hospitals, General Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pediatric Brain Tumor Market is driven by expanding pediatric oncology diagnostics, brain tumor screening technologies, neuroimaging diagnostics, ... Read More

Published Date: JAN-2026 | No Of Pages:191 | $ 4485

Optic Neuritis Treatment Market By Treatment Type (Corticosteroids, Immunomodulators & Disease-Modifying Therapies, Monoclonal Antibodies, Plasma Exchange & Others); By Indication (MS-Associated Optic Neuritis, NMOSD, Infectious & Other Autoimmune Causes); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Specialty & Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Optic Neuritis Treatment Market is witnessing growth at CAGR of 8.1%, expanding from USD 1.7 billion in 2024 to USD 2.9 billion by 2030, propelled by Read More

Published Date: JAN-2026 | No Of Pages:150 | $ 4485

Multiple System Atrophy Market By Treatment Type (Symptomatic Therapies, Disease-Modifying Pipeline, Supportive Devices); By Diagnosis (Imaging, Fluid Biomarkers, Clinical Assessment); By End User (Hospitals, Neurology Clinics, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Multiple System Atrophy Market is forecast to register a CAGR of 8.6%, valued at USD 380 million in 2024 and reaching USD 625 million by 2030, driven by <... Read More

Published Date: JAN-2026 | No Of Pages:184 | $ 4485

Refractory Epilepsy Treatment Market By Treatment Type (Anti-Epileptic Drugs, Vagus Nerve Stimulation, Responsive Neurostimulation, Deep Brain Stimulation, Surgical Resection, Dietary Therapies); By Route of Administration (Oral, Injectable, Implanted Devices); By End User (Hospitals, Neurology Clinics, Pediatric Epilepsy Centers, Ambulatory Surgery Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Refractory Epilepsy Treatment Market is projected to grow at a robust CAGR of 6.9%, valued at USD 6.7 billion in 2024 and expected to surpass USD 10.1 billion by 2... Read More

Published Date: JAN-2026 | No Of Pages:177 | $ 4485

Post Bariatric Hypoglycemia Market By Treatment Type (Pharmacologic, Nutritional, Surgical Revision, Device-Assisted Monitoring); By Patient Profile (Early Onset PBH, Late Onset PBH, Refractory PBH, Asymptomatic PBH); By End User (Bariatric Surgery Centers, Endocrinology Clinics, Digital Therapeutics Platforms, General Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Post Bariatric Hypoglycemia Market valued at USD 1.1 billion in 2024 and expected to reach USD 1.6 billion by 2030 at CAGR of 6.8%, propelled by h... Read More

Published Date: JAN-2026 | No Of Pages:197 | $ 4485

Hyperuricemia Market By Drug Class (Xanthine Oxidase Inhibitors, Uricosuric Agents, Uricase-Based Biologics, Combination Therapies); By Type (Asymptomatic Hyperuricemia, Symptomatic Hyperuricemia); By Route of Administration (Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, Online Channels); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hyperuricemia Market is projected to grow from USD 5.8 billion in 2024 to USD 8.3 billion by 2030, registering a CAGR of 6.1%, driven by rising gout preva... Read More

Published Date: JAN-2026 | No Of Pages:155 | $ 4485

Inflammatory Myopathy Market By Type (Polymyositis, Dermatomyositis, Inclusion Body Myositis, Necrotizing Autoimmune Myopathy, Others); By Treatment (Corticosteroids, Immunosuppressants, Intravenous Immunoglobulin (IVIG), Biologics, Others); By Route of Administration (Oral, Intravenous, Subcutaneous); By End User (Hospitals, Specialty Clinics, Home Infusion Providers, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Inflammatory Myopathy Market valued at USD 1.65 billion in 2024 and projected to reach USD 2.4 billion by 2030 at 6.4% CAGR, reflecting market gro... Read More

Published Date: JAN-2026 | No Of Pages:193 | $ 4485

Refractory Angina Treatment Market By Treatment Type (EECP, Coronary Sinus Reducers, Spinal Cord Stimulation, Transmyocardial Laser Revascularization, Cell & Gene Therapy, Pharmacologic Agents); By Mechanism of Action (Neuromodulation, Vascular Modulation, Hemodynamic Therapy, Regenerative Therapy, Metabolic Modulation); By End User (Tertiary Care Hospitals, Cardiology Specialty Clinics, Pain Management Centers, Outpatient Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Refractory Angina Treatment Market will witness a steady CAGR of 6.2%, valued at USD 1.6 billion in 2024 and projected to reach USD 2.3 billion by 2030, a... Read More

Published Date: JAN-2026 | No Of Pages:162 | $ 4485

Pertussis Treatment Market By Treatment Type (Macrolides, Sulfonamides, Combination Therapies, Vaccines); By Route of Administration (Oral, Injectable); By Distribution Channel (Hospitals, Retail Pharmacies, Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pertussis Treatment Market is projected to grow from USD 3.2 billion in 2024 to USD 4.9 billion by 2030 at a 7.3% CAGR, driven by rising vaccination programs, antibiotic therapies, and ped... Read More

Published Date: JAN-2026 | No Of Pages:155 | $ 4485

Paraganglioma Treatment Market by Treatment Type (Surgical Treatment, Radiotherapy, Pharmacological Treatment); By End-User (Hospitals, Diagnostic Imaging Centers, Research Institutes, Ambulatory Surgical Centers); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa); Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Paraganglioma Treatment Market valued at USD 1.2 billion in 2024 and forecast to reach USD 1.8 billion by 2030 at 5.3% CAGR, fueled by therapeutic... Read More

Published Date: JAN-2026 | No Of Pages:172 | $ 4485

Tonic-Clonic Seizure Market By Drug Class (Traditional AEDs, New-generation AEDs); By Route of Administration (Oral, Intravenous, Intranasal, Rectal); By Age Group (Pediatric, Adult, Geriatric); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Tonic- Clonic Seizure Market will witness growth at CAGR of 5.8%, climbing from USD 1.87 billion in 2024 to USD 2.62 billion by 2030, supported by Read More

Published Date: JAN-2026 | No Of Pages:189 | $ 4485

Transverse Myelitis Market By Treatment Approach (Corticosteroids, Plasma Exchange, IVIG, Immunosuppressants, Biologics); By Route of Administration (Intravenous, Oral, Subcutaneous); By End User (Hospitals, Specialty Clinics, Home Care, Rehabilitation Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Transverse Myelitis Market will witness a robust CAGR of 6.5%, valued at $654 million in 2024, expected to appreciate and reach $961 million by 2030, acco... Read More

Published Date: JAN-2026 | No Of Pages:152 | $ 4485

Propionic Acidemia Market by Treatment Type (Dietary Management, Enzyme Replacement Therapy, Gene Therapy, Liver Transplantation); By Age Group (Newborns & Infants, Children & Adolescents, Adults); By Diagnostic Type (Newborn Screening, Genetic Testing, Metabolic Panel Tests); By End-User (Hospitals, Diagnostic Centers, Research Institutions, Specialty Clinics); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Propionic Acidemia Market valued at USD 0.7 billion in 2024 and forecast to reach USD 1.1 billion by 2030 at 7.1%, CAGR, supported by market size<... Read More

Published Date: JAN-2026 | No Of Pages:162 | $ 4485

Pheochromocytoma Treatment Market By Treatment Type (Surgical Resection, Systemic Therapy, Pre-operative Stabilization, Genetic Surveillance); By Drug Class (Alpha Blockers, Beta Blockers, Tyrosine Kinase Inhibitors, Radiopharmaceuticals, Chemotherapy); By End User (Tertiary Hospitals, Oncology Centers, Endocrinology Clinics, Nuclear Medicine Facilities); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pheochromocytoma Treatment Market is projected to reach USD 1.12 billion by 2030, growing from an estimated USD 750 million in 2024, reflecting a steady CAGRRead More

Published Date: JAN-2026 | No Of Pages:151 | $ 4485

Hypophosphatasia Treatment Market By Therapy Type (Enzyme Replacement Therapy, Gene Therapy, Small Molecule Enzyme Activators, Supportive Therapies); By Route of Administration (Intravenous, Subcutaneous, Oral); By Patient Population (Perinatal & Infantile, Childhood, Adult); By Distribution Channel (Hospital Pharmacies, Specialty Distributors, Home Infusion Services); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hypophosphatasia Treatment Market is projected to grow at a robust CAGR of 10.6%, valued at USD 620.0 million in 2024, a... Read More

Published Date: JAN-2026 | No Of Pages:172 | $ 4485

Ischemic Stroke Market By Treatment Type (Thrombolytics, Mechanical Thrombectomy Devices, Antiplatelet Drugs, Anticoagulants, Others); By Diagnosis Modality (CT, MRI, Biomarkers, Others); By End User (Hospitals, Neurology Clinics, Ambulatory Surgical Centers, Rehabilitation Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Ischemic Stroke Market is set to expand at a consistent CAGR of around 6.8%, increasing from nearly $12.6 billion in 2024 to $18.7 billion by 2030, fueled... Read More

Published Date: JAN-2026 | No Of Pages:168 | $ 4485

Pediatric Growth Hormone Deficiency Market by Treatment Type (Recombinant Human Growth Hormone [rhGH], Growth Hormone Secretagogues, Gene Therapy); By Age Group (Children 0-12 Years, Adolescents 13-18 Years); By Mode of Administration (Subcutaneous Injections, Long-acting Growth Hormones, Non-injection Methods [Intranasal, Oral]); By End-User (Pediatric Hospitals, General Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers [ASCs]); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pediatric Growth Hormone Deficiency Market will record CAGR of 7.2% from 2024 to 2030, rising from USD 3.2 billion in 2024 to USD 5.4 billion by 2030, dri... Read More

Published Date: JAN-2026 | No Of Pages:154 | $ 4485

AL Amyloidosis Therapeutics Market By Drug Class (Proteasome Inhibitors, Monoclonal Antibodies, Immunomodulatory Drugs, Chemotherapy, Novel Targeted Therapies); By Route of Administration (Intravenous, Subcutaneous, Oral); By End User (Hospitals, Specialty Hematology/Oncology Clinics, Outpatient Infusion Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global AL Amyloidosis Therapeutics Market is projected to reach around $3.6 billion by 2030 from $2.4 billion in 2024, growing at a CAGR of 7.0%, driven by Read More

Published Date: JAN-2026 | No Of Pages:166 | $ 4485

Advanced Liver Cancer Market By Therapy Type (Targeted Therapy, Immunotherapy, Chemotherapy, Others); By Biomarker Status (Biomarker-Positive, Biomarker-Negative/Undifferentiated); By End User (Specialty Oncology Hospitals, General Hospitals & Clinics, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Advanced Liver Cancer Market is estimated to be valued at USD 10.8 billion in 2024 , projected to grow steadily and reach around USD 18.2 billion by 2030 , expanding at a ... Read More

Published Date: JAN-2026 | No Of Pages:156 | $ 4485

Advanced Cancer Pain Management Market By Product Type (Pharmaceutical Therapies, Medical Devices); By Route of Administration (Oral, Transdermal, Parenteral, Implantable Devices); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Clinics, Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Advanced Cancer Pain Management Market is on a clear growth path, with a value of USD 9.8 billion in 2024 and projected to reach around USD 13.7 billion by 2030 with a Read More

Published Date: JAN-2026 | No Of Pages:179 | $ 4485

Acute Radiation Syndrome Market By Product Type (Pharmaceuticals, Medical Devices, Supportive Therapies); By Route of Administration (Intravenous, Oral); By Application (Emergency Response, Oncology Support, Industrial Accidents); By End User (Hospitals, Government Agencies, Military Units, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Acute Radiation Syndrome (ARS) Market will expand at a steady CAGR of 6.5%, rising from $923 million in 2024 to $1.35 billion by 2030, fueled by r... Read More

Published Date: JAN-2026 | No Of Pages:189 | $ 4485

Acute Intermittent Porphyria Market By Drug Class (Intravenous Hemin, RNAi Therapy, Gene-based Therapy, Others); By Route of Administration (Intravenous, Subcutaneous, Oral, Others); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Acute Intermittent Porphyria Market will grow significantly at a CAGR of 13.8%, valued at USD 1.1 billion in 2024 and forecasted to reach USD 2.4 billion by 2030Read More

Published Date: JAN-2026 | No Of Pages:176 | $ 4485

Acrocallosal Syndrome Market By Treatment Approach (Gene Therapies, RNA-Based Therapies, Symptomatic Treatment); By End User (Hospitals, Diagnostic Labs, Home Care Providers, Pharmaceutical Companies, Government and Nonprofit Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Acrocallosal Syndrome Market is valued at approximately USD 500 million in 2024 and is projected to reach USD 1.2 billion by 2030 , growi... Read More

Published Date: JAN-2026 | No Of Pages:167 | $ 4485

Acoustic Neuroma Market By Treatment Type (Surgical Treatment, Radiosurgery [Gamma Knife, CyberKnife], Pharmacological Treatment, Watchful Waiting); By Diagnostic Modality (MRI, CT, Audiometry, Ultrasound, ENG); By End User (Hospitals, Specialized Clinics, Research Institutions, Diagnostic Imaging Centers, Patients); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Acoustic Neuroma Market with USD 1.2 billion in 2024, expected to rise to USD 2.2 billion by 2030 growing at 6.5%, CAGR, influenced by acoustic ne... Read More

Published Date: JAN-2026 | No Of Pages:153 | $ 4485